Related Experiment Video
Updated: Sep 16, 2025

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Delayed Diagnoses of Cardiac Amyloidosis
Cooper B Kersey1, Graham Bevan1, Douglas Leedy1
1Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Diagnosing cardiac sarcoidosis is difficult. Multimodality imaging can misdiagnose it, with three cases reclassified to wild-type transthyretin cardiac amyloidosis after biopsy.
Area of Science:
- Cardiology
- Medical Imaging
- Histopathology
Background:
- Cardiac sarcoidosis (CS) diagnosis is challenging due to low endomyocardial biopsy sensitivity.
- Cardiac 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has limited specificity for CS.
Observation:
- Three patients were initially diagnosed with isolated CS.
- Diagnosis was based on multimodality cardiac imaging findings.
Findings:
- Endomyocardial biopsy histopathology definitively reclassified these patients.
- The confirmed diagnosis for all three was wild-type transthyretin cardiac amyloidosis.
Implications:
- This highlights potential diagnostic pitfalls in CS evaluation.
- Multimodality imaging findings must be carefully correlated with histopathology.
- Distinguishing CS from cardiac amyloidosis is critical for appropriate treatment.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

